Meeting
2012 Genitourinary Cancers Symposium
Phase I trial of cabazitaxel plus cisplatin in patients with advanced solid tumors.
Authors
Albert C. Lockhart
Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
Albert C. Lockhart , Shankar Sundaram , John Sarantopoulos , Monica M. Mita , Alex R. Lane , Jennifer L. Moseley , Jean-Francois Dedieu , Diane Stash , Xin Zhi , Florent Mazuir , Alain C. Mita
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer
Clinical Trial Registration Number
NCT00925743
Citation
J Clin Oncol 30, 2012 (suppl 5; abstr 162)
DOI
10.1200/jco.2012.30.5_suppl.162
Abstract #
162
Poster Bd #
D25
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Phase I study of cabazitaxel (Cbz) plus cisplatin (Cis) in patients (pts) with advanced solid tumors: Substudy to evaluate the impact of a strong CYP3A inhibitor (ketoconazole; K) or inducer (rifampicin; R) on the pharmacokinetics (PK) of Cbz.
First Author: Alain C. Mita
Poster
2023 ASCO Annual Meeting
Phase 1 studies of D07001-F4 and D07001-softgel capsule: Oral metronomic gemcitabine in subjects with advanced solid tumors.
First Author: Chia-Chi Lin
Poster
2023 ASCO Annual Meeting
A phase I study of nelmastobart (hSTC810), an anti-BTN1A1 antibody, in patients with advanced solid tumors.
First Author: Soohyeon Lee
Poster
2022 ASCO Annual Meeting
A phase I trial of elimusertib in combination with cisplatin or with cisplatin plus gemcitabine in advanced solid tumors with an emphasis on urothelial carcinoma.
First Author: Ryan Leibrandt